CRISPR-based assays for low-resource settings.
Where this comes from
- Record sourced from PubMed, PMID 37064656.
- Also identified by DOI 10.1038/s44222-023-00026-8 and PMC identifier 9875755.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
CRISPR-based assays can be adopted as ultrasensitive molecular diagnostics in resource-limited settings, but point-of-care applications must address additional requirements. Here, we discuss the major obstacles for developing these assays and offer insights into how to surmount them.